Format

Send to

Choose Destination
Rev Alerg Mex. 2017;64 Suppl 1:s11-s128.

[Mexican Asthma Guidelines: GUIMA 2017].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Hospital Médica Sur, Centro de Investigación. Ciudad de México. marlar1@prodigy.net.mx.
2
Secretaría de Salud, Instituto Nacional de Enfermedades Respiratorias, Dirección General. Ciudad de México, México. jsalas@iner.gob.mx.

Abstract

in English, Spanish

BACKGROUND:

The need for a national guideline, with a broad basis among specialists and primary care physicians was felt in Mexico, to try unifying asthma management. As several high-quality asthma guidelines exist worldwide, it was decided to select the best three for transculturation.

METHODS:

Following the internationally recommended methodology for guideline transculturation, ADAPTE, a literature search for asthma guidelines, published 1-1-2007 through 31-12-2015 was conducted. AGREE-II evaluations yielded 3/40 most suitable for transculturation. Their compound evidence was fused with local reality, patient preference, cost and safety considerations to draft the guideline document. Subsequently, this was adjusted by physicians from 12 national medical societies in several rounds of a Delphi process and 3 face-to-face meetings to reach the final version.

RESULTS:

Evidence was fused from British Thoracic Society Asthma Guideline 2014, Global Initiative on Asthma 2015, and Guía Española del Manejo del Asma 2015 (2016 updates included). After 3 Delphi-rounds we developed an evidence-based document taking into account patient characteristics, including age, treatment costs and safety and best locally available medication.

CONCLUSIONS:

In cooperation pulmonologists, allergists, ENT physicians, paediatricians and GPs were able to develop an evidence-based document for the prevention, diagnosis and treatment of asthma and its exacerbations in Mexico.

KEYWORDS:

Asthma; Asthmatic exacerbation; Bronchodilator; Clinical practice guideline; Immunotherapy; Inhaled corticosteroid; Spirometry

PMID:
28441001
DOI:
10.29262/ram.v64i0.272

Supplemental Content

Loading ...
Support Center